| CBHMX | SMNIX | CBHMX / SMNIX | |
| Total Expense Ratio | 0.56 | 2.25 | 25% |
| Annual Report Gross Expense Ratio | 0.73 | 2.25 | 32% |
| Fund Existence | 5 years | 4 years | - |
| Gain YTD | 6.418 | 1.420 | 452% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 3000 | 100000 | 3% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.68B | 107M | 2,501% |
| Annual Yield % from dividends | 4.24 | 3.77 | 112% |
| Returns for 1 year | 7.64 | 0.25 | 3,054% |
| Returns for 3 years | 9.66 | 8.14 | 119% |
| Returns for 5 years | 8.68 | N/A | - |
| Returns for 10 years | N/A | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FIJYX | 41.15 | N/A | N/A |
| Fidelity Advisor Biotechnology Z | |||
| AAIPX | 19.50 | -0.10 | -0.51% |
| American Beacon International Eq Inv | |||
| GEMQX | 14.74 | -0.22 | -1.47% |
| Goldman Sachs Emerging Mkts Eq ex. Chn R | |||
| TVOIX | 40.72 | -0.70 | -1.69% |
| Touchstone Small Cap Value Institutional | |||
| ASLGX | 145.38 | -3.23 | -2.17% |
| American Century Select R5 | |||